10.22.25 -- The Key To Outsourcing Is Timing, Not Timelines

Explore how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.

Understand how softgel technology enhances rapid drug absorption and precise dosing, offering crucial benefits for high-potency oncology treatments and improving overall therapeutic performance.

The development of physically stable, biologically active dry powder formulations of large molecules for inhalation has remained a persistent challenge within the biopharmaceutical industry.

Leave it to an Outsourced Pharma Live digital discussion to ask the questions others leave out. How much de-risking is too much? When can you sleep at night knowing your supply chains are as they should be, and you can fully rely on them? Oh, and we answer questions such as these as well.

As molecular complexity continues to increase, flow chemistry is becoming an essential enabling technology to facilitate the integration of complex synthetic methods into API production.

As process chemists face new challenges, review advanced retrosynthetic analysis services and discover how these tools enable the development of innovative small molecule drugs more efficiently.

Failure to identify a compound’s red flags early in development often manifests as program delays or failures. Discover how to avoid these setbacks through complete molecular characterization.

As the top industry partner for development, launch, and supply of new treatments, we offer integrated solutions for pulmonary and nasal delivery with significant capacity in North America.

Our global network spans nine sites in five countries, supporting NCE programs from discovery to commercialization with a cost-efficient model that simplifies outsourcing.